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Abstract
In the past 4 decades about 500 randomized
trials have examined the effects of psychological treatments of
adult depression. In this article the results of a series of meta-
analyses of these trials are summarised. Several types of psycho-
therapy have been examined, including cognitive behaviour ther-
apy, behavioural activation therapy, interpersonal psychotherapy,
problem-solving therapy, nondirective supportive therapy, and
short-term psychodynamic psychotherapy. All therapies are effec-
tive and there are no significant differences between treatments.
Psychotherapies are about equally effective as pharmacotherapy,
and combined treatments are more effective than either of these
alone. Therapies are also effective in specific target groups, such as
older adults, college students, patients with general medical disor-
ders, but may be somewhat less effective in chronic depression,
and in patients with comorbid substance use disorders. Treatments
are effective when delivered in individual, group, and guided self-
help format. The effects of psychotherapies have been overesti-
mated because of the low quality of many trials and due to publica-
tion bias. Future research should not be aimed at the development
of new psychotherapies for depression, on specific treatment for-
mats or on therapies in specific populations, because the evidence
indicates that all types and formats with human involvement are
effective in all specific target groups. Future research should in-
stead focus on a further reduction of the disease burden of depres-
sion. Specifically, it should focus on the possibilities of preventing
the onset of depressive disorders, treatments of chronic and
treatment-resistant depression, relapse prevention, and scaling up
treatments, for example by using more guided self-help
interventions.
Keywords: depression, meta-analysis, psychotherapy, psychological
treatment, cognitive behaviour therapy
Depressive disorders are highly prevalent (Alonso et al., 2004;
Kessler et al., 1994), have a high incidence (Waraich, Goldner,
Somers, & Hsu, 2004), and they are associated with a substantial loss
of quality of life for patients and their relatives (Saarni et al., 2007;
Ustun, Ayuso-Mateos, Chatterji, Mathers, & Murray, 2004). These
disorders are also associated with increased mortality rates (Cuijpers,
Vogelzangs et al., 2014), high levels of service use, and enormous
economic costs (Greenberg & Birnbaum, 2005; Smit et al., 2006).
Major depression is currently ranked fourth worldwide in disease
burden. Depression is expected to rank first in disease burden in
high-income countries by the year 2030 (Mathers & Loncar, 2006). It
is not surprising therefore that several treatments of depression have
been developed in the past decades and that a considerable body of
research has examined the effects of these treatments. There are two
main categories of treatments for depression: biological treatments
(mostly antidepressant medications) and psychological treatments.
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Both types have been examined extensively. Since the 1970s about
500 randomized controlled trials have examined the effects of psy-
chological treatments on depression.
It is now about 10 years since we started to build a compre-
hensive database of randomized trials examining the effects of
psychological treatments of depression. Since that time we have
updated this database every year (Cuijpers, van Straten, Smit,
Mihalopoulos, & Beekman, 2008). We have used this database
to answer several research questions with meta-analyses. We
have published more than 70 of such meta-analyses. We have
examined which psychotherapies are effective, whether psycho-
therapy is as effective as pharmacotherapy, and whether com-
bined treatments are more effective than psychotherapy or
pharmacotherapy alone. We have also examined the effects of
the therapies in specific target groups, settings and subtypes of
depression, as well characteristics of the therapies, such as the
format (individual, group, self-help), and the number of ses-
sions. We have examined the quality of the trials and how this
affects their outcomes of the therapies, as well as the problem
of publication bias. In this article we will give an overview of
the results of these meta-analyses. We already provided an
overview in an earlier article (Cuijpers, Andersson, Donker, &
Van Straten, 2011). However, since then a considerable number
of new meta-analyses have been published. This article can be
seen as an update of this earlier overview.
A Database of Randomized Trials of Psychotherapies
for Adult Depression
The methods used for building the database and the analyses
used in the meta-analyses have been published in a methods
article (Cuijpers, Van Straten, Smit et al., 2008). The general
methods we used in these meta-analyses have been described in
a manual that is freely available (Cuijpers, 2016b). In brief, the
database was developed through a comprehensive literature
search (of works dating from 1966), and is updated every year.
We searched major bibliographical databases (PsycINFO,
PubMed, Embase, Cochrane Central Register of Controlled
Trials). We include all randomized trials in which at least one
arm is a psychological treatment for adults (18 years) with a
depressive disorder according to a diagnostic interview or an
elevated level of depressive symptomatology (as indicated by a
score above a cut-off score on a validated self-report depression
scale like the Beck Depression Inventory).
We calculate standardized mean effects (Cohen’s d or
Hedges’ g) for each comparison between a psychotherapy and a
comparison group, indicating the difference between these groups
in terms of standard deviations. Effect sizes of 0.8 can be assumed
to be large, while effect sizes of 0.5 are moderate, and effect sizes
of 0.2 are small (Cohen, 1988). An effect size is, however, still a
statistical concept with no direct indication for clinical relevance.
Elsewhere we have argued that an effect size of d  0.24 may be
a threshold for clinical relevance in depression.
Because effect sizes are difficult to interpret for patients and
clinicians we also calculate in most meta-analyses the numbers-
needed-to-treat (NNT). The NNT indicates how many patients
should receive the treatment to have one more positive outcome
compared with the comparison group (Kraemer & Kupfer, 2006;
Laupacis, Sackett, & Roberts, 1988).
In all meta-analyses we pool the individual effect sizes accord-
ing to the random effects model. We calculate the level of heter-
ogeneity with I2 and its 95% confidence interval (CI). We also
calculate in all meta-analyses the small sample bias (usually con-
sidered to be an indicator for publication bias), by examining the
asymmetry of the funnel plot (showing that more small studies
with large effect sizes are published than small studies with small
or negative effect sizes). Details of these methods can be found
elsewhere (Cuijpers, 2016b).
In Figure 1 the 400 randomized trials on psychotherapy that
were included up to January 1, 2014 are presented in 5-year
intervals. In the 1970s and 1980s almost all trials were conducted
in the United States. Since the second half of the 1990s, the
number of trials in Europe has increased considerably. In recent
years more trials are conducted in Europe than in North America.
Since 2000 an increasing number of trials has also been conducted
Figure 1. Randomized controlled trials examining the effects of psychotherapies for adult depression (N 
400; published previously in Cuijpers, 2015). See the online article for the color version of this figure.
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in non-Western countries. The total number of trials has increased
sharply since the 1990s.
The Effects of Psychotherapies for Depression
Several different types of psychotherapy have been developed
and tested. All have been found to be effective compared with
waiting list, care-as-usual, and placebo control conditions. The
therapies that have been compared with a control group in at least
10 randomized trials are listed in Table 1. These therapies are
cognitive behaviour therapy (CBT), behavioural activation ther-
apy, interpersonal psychotherapy (IPT), problem-solving therapy,
nondirective supportive therapy, and short-term psychodynamic
psychotherapy (the definitions for each of these therapies are given
in Cuijpers, Van Straten, Andersson, & van Oppen, 2008). For
each of these therapies we conducted separate meta-analyses. As
can be seen in Table 1, the effect sizes for these therapies range
from g  0.58 for nondirective counselling to g  0.83 for
problem-solving therapies, with NNTs from 2 to 3. CBT is by far
the most studied type of psychotherapy for depression.
The effect sizes found for these therapies do not significantly
differ from each other (Barth et al., 2013). However, the effect
sizes are dependent on the type of control group. Waiting list
control groups typically have the largest effect sizes (usually g 
0.8; Barth et al., 2013), care-as-usual has an effect size of about
g  0.5, and pill placebo has an effect size of 0.25 (Cuijpers,
Turner et al., 2014).
Although these outcomes were examined at posttest, directly
after the therapy, there is also evidence that the effects of psycho-
therapy are longer lasting. In one meta-analysis we found that the
odds of a positive outcome at 6 months after randomization was
significantly better for those who received the therapy compared
with the odds in the control groups (OR  1.92; 95% CI [1.60,
2.31]; Table 2; Karyotaki et al., 2016). In another meta-analysis we
found that the odds of a positive outcome was also better at 12
months postrandomization (OR  1.59; 95% CI [1.14, 2.21];
Karyotaki et al., 2014).
Most trials have focused on depression as primary outcome.
However, a considerable number of trials have examined other,
secondary outcomes of psychotherapy for depression. The results
of the meta-analyses in which we examined these secondary out-
comes are summarised in Table 1. As can be seen, psychological
treatments seem to also have positive effects on quality of life
Table 1
Psychological Treatments of Adult Depression: Comparisons With Control Groups, Comparisons Between Different Types of
Psychotherapy and Comparisons With Pharmacotherapy
N g 95% CI I2 95% CI NNT Reference
Different types of psychotherapy versus control groups
• Cognitive behavior therapy 94 .71 [.62, .79] 57 [44, 65] 3 (Cuijpers, Berking et al., 2013)
• Behavioral activation therapy 31 .74 [.56, .91] 41 [11, 62] 3 (Ekers et al., 2014)
• Interpersonal psychotherapy 31 .60 [.45, .75] 63 [43, 74] 3 (Cuijpers, Donker et al., 2016)
• Problem-solving therapy 13 .83 [.45, 1.21] 83 [71, 88] 2 (Cuijpers, van Straten, & Warmerdam, 2007)
• Nondirective supportive therapy 18 .58 [.45, .72] 0 [0, 44] 3 (Cuijpers et al., 2012)
• Short-term psychodynamic psychotherapy 10 .61 [.33, .88] 54 [0, 76] 3 (Driessen, Hegelmaier et al., 2015)
Direct comparisons of different types of psychotherapya
• Cognitive behavior therapy vs. all other therapies 46 .02 [.07, .11] 14 [0, 41] 83 (Cuijpers, Berking, et al., 2013)
• Nondirective supportive therapy vs. all other therapies 30 .20 [.32, .08] 29 [0, 54] 9 (Cuijpers et al., 2012)
• Behavioral activation therapy vs. all other therapies 21 .14 [.02, .30] 0 [0, 41] 13 (Cuijpers, van Straten, Andersson et al., 2008)
• Psychodynamic therapy vs. all other therapies 15 .25 [.49, .02] 63 [24, 77] 7 (Driessen, Hegelmaier et al., 2015)
• Problem-solving therapy vs. all other therapies 7 .40 [.07, .88] 73 [23, 86] 5 (Cuijpers, van Straten, Andersson et al., 2008)
• Interpersonal psychotherapy vs. all other therapies 14 .06 [.14, .26] 52 [0, 72] 29 (Cuijpers, Donker et al., 2016)
Psychotherapy versus pharmacotherapy and combined treatmentsa
• Psychotherapy vs. pharmacotherapy 48 .03 [.14, .08] 52 [0, 47] 63 (Cuijpers, Sijbrandij et al., 2013)
• Psychotherapy vs. combined treatment 19 .35 [.24, .45] 0 [0, 43] 5 (Cuijpers, van Straten, Warmerdam et al., 2009)
• Pharmacotherapy vs. combined treatment 32 .41 [.28, .54] 50 [25, 67] 4 (Cuijpers, Sijbrandij et al., 2014)
• Combined vs. psychotherapy plus placebo 16 .25 [.03, .46] 57 [13, 74] 7 (Cuijpers, van Straten, Hollon et al., 2010)
Effects of psychotherapies compared with control groups on other outcomes than depressive symptoms
• Quality of life 31 .33 [.24, .42] 21 [0, 49] 5 (Kolovos et al., 2016)
• Suicidality 4 .12 [.20, .44] 31 [0, 77] 15 (Cuijpers, de Beurs, et al., 2013)
• Hopelessness 18 1.10 [.72, 1.48] 77 [62, 84] 2 (Cuijpers, de Beurs, et al., 2013)
• Dysfunctional thinking 21 .51 [.39, .62] 6 [0, 45] 4 (Cristea et al., 2015)
• Social functioning 39 .46 [.32, .60] 71 [58, 78] 4 (Renner, Cuijpers, & Huibers, 2014)
• Positive affect 8 .37 [.13, .60] 39 [0, 73] 5 (Boumparis et al., 2016)
• Negative affect 8 .40 [.31, .68] 73 [44, 87] 5 (Boumparis et al., 2016)
• Social support 15 .38 [.29, .48] 0 [0–54] 5 (Park et al., 2014)
• Mental health children 7 .40 [.22, .59] 1 [0, 71] 5 (Cuijpers et al., 2015)
• Mother–child interaction 8 .35 [.17, .52] 0 [0, 68] 5 (Cuijpers et al., 2015)
• Parental functioning 5 .67 [.30, 1.04] 51 [0, 82] 3 (Cuijpers et al., 2015)
Note. CI  confidence interval; N  number of comparisons; NNT  numbers-needed-to-treat.
a In these comparisons a positive sign indicates that the first treatment of column one is more effective than the second one.
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(Kolovos, Kleiboer, & Cuijpers, 2016), hopelessness (Cuijpers, de
Beurs et al., 2013), on dysfunctional thinking (Cristea et al., 2015),
on positive and negative affect (Boumparis, Karyotaki, Kleiboer,
Hofmann, & Cuijpers, 2016), and on social support (Park, Cuijpers,
van Straten, & Reynolds, 2014). There is also a small group of studies
examining the effects of psychotherapy for depressed mothers on the
mental health of their children (Cuijpers, Weitz, Karyotaki, Garber, &
Andersson, 2015). These studies show an overall effect on the mental
health of these children, on the mother–child interaction and on
parental functioning in general. Unexpectedly, very few studies have
examined the effects of psychotherapy for depression on suicidality
(Cuijpers, de Beurs et al., 2013). The effects of psychotherapy on
suicidality remains therefore unclear. In the meta-analyses examining
these secondary outcomes we typically find a strong association
between the effects of therapies on depression and those on the
secondary outcomes.
In a recent meta-analysis conducted by another group (Johnsen
& Friborg, 2015) it was suggested that the effects of CBT have
been falling over time. However, this meta-analysis had several
serious methodological and conceptual problems. Therefore, we
decided to redo this study (Cristea et al., in press). We used the
same inclusion criteria as the original meta-analysis, but limited
these to randomized trials. We identified 30 additional trials that
had been missed in the original meta-analysis. In this larger sam-
ple, we did confirm the significant association between year of
publication and the effect size (although this was based on prepost
effect sizes, which are known to have many methodological prob-
lems; Cuijpers et al., 2016). However, the heterogeneity in these
analyses was so high (90%) that these outcomes can hardly be
interpreted. Furthermore, this drop in effects over time was only
found in the United States where early studies showed very high
effect sizes. Studies from other parts of the world and more recent
studies in the U.S. did not point at such an association. Year of
publication does not appear to be a stable, reliable, and indepen-
dent moderator of the effectiveness of CBT for depression. The
temporal trend that was suggested in the original study is most
likely a statistical artifact.
Are All Psychotherapies Equally Effective in the
Treatment of Depression?
We can conclude that effect sizes from types of psychotherapy
(compared with control groups) do not significantly differ from
each other, suggesting that all therapies have comparable effects.
However, a much better way to examine whether different types of
psychotherapy are actually equally effective is to examine studies
in patients who are randomly assigned to two (or more) different
types of psychotherapy. If there are differences after treatment this
can be considered direct evidence that therapies are indeed not
equally effective.
In several meta-analyses we have examined these studies with
direct comparisons between therapies (Barth et al., 2013; Cuijpers,
Berking et al., 2013; Cuijpers, Donker, Weissman, Ravitz, &
Cristea, 2016; Cuijpers et al., 2012; Cuijpers, van Straten,
Andersson et al., 2008; Driessen, Hegelmaier et al., 2015). We
have summarised the differential effect sizes found in these meta-
analyses in Table 1. Overall we found few indications that there
are significant and clinically relevant differences between studies.
We did find that nondirective counselling was somewhat less
effective than other therapies. However, in a more detailed study,
we found that studies comparing counselling with another therapy
often use counselling as a “nonspecific” control group. Further-
more, many of these studies suffer from researcher allegiance
against counselling (Cuijpers et al., 2012). In studies with no
researcher allegiance the difference between counselling and other
therapies was not significant. We also found that brief psychody-
namic therapies were somewhat less effective than other therapies
(Driessen, Hegelmaier et al., 2015). This difference was also small
and may not be robust when more research is done in this area.
Some researchers consider this absence of a difference between
therapies to be evidence that the effects are not realised by therapy-
specific mechanisms but by the so-called “common factors.” A
well-known example of such a common factor is the alliance
between therapist and patient (Wampold & Imel, 2015). It is
beyond the scope of the current article to list all arguments why
this conclusion cannot be drawn from these studies. However, one
important issue in this debate is that both the statistical power and
the methodological quality is usually far too low in almost all
studies directly comparing different therapies (Cuijpers, 2016a). In
one article, we showed that in the studies examining CBT, IPT,
and psychodynamic therapies, none of the individual trials had
enough power to detect an effect size smaller than g  0.34 (while
the threshold for a clinically relevant effect is g  0.24; Cuijpers,
Turner, Koole, van Dijke, & Smit, 2014). Pooling of these studies
in meta-analyses may help with solving the problem of low sta-
Table 2
Long-Term Effects of Psychotherapies for Depression: Odds Ratios
N OR 95% CI I2 95% CI Reference
Therapy vs. control
• Response at  6 months 55 1.92 [1.60, 2.31] 65 [53, 74] (Karyotaki et al., 2016)
• Response at  12 months 11 1.59 [1.14, 2.21] 55 [17, 75] (Karyotaki et al., 2014)
Combined vs. pharmacotherapy
• Response at  6 months 13 2.93 [2.15, 3.99] 0 [0, 57] (Karyotaki et al., 2016)
• Response at  12 months 8 2.23 [1.43, 3.41] 0 [0, 68] (Karyotaki et al., 2016)
Combined vs. psychotherapy
• Response at  6 months 8 1.42 [.97, 2.0]7 0 [0, 68] (Karyotaki et al., 2016)
• Response at  12 months 7 1.33 [.88, 2.14] 0 [0, 71] (Karyotaki et al., 2016)
Note. CI  confidence interval; N  number of comparisons.
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tistical power. However, after exclusion of studies of low quality
even pooling these studies in meta-analyses does not result in
sufficient power to find clinically relevant effect sizes.
Psychotherapy and Pharmacotherapy
Our meta-analyses of trials directly comparing psychotherapies
and pharmacotherapy for depression indicate that there are no
major differences between these two types of treatment (Cuijpers,
Sijbrandij et al., 2013; Cuijpers, Van Straten, van Oppen, &
Andersson, 2008, 2010). In the largest and most recent meta-
analysis of these trials directly comparing psychotherapy and
pharmacotherapy (Cuijpers, Sijbrandij et al., 2013), we found a
differential effect size of g  0.03 (in favour of pharmacother-
apy), which was neither significant nor clinically relevant.
One problem is that in some trials directly comparing therapy
with pharmacotherapy there is also a placebo condition. Such a
placebo condition is not present in other trials. In these trials, the
patients in the pharmacotherapy condition are blinded and do not
know whether they are using the medication or the placebo. This
is not the case in psychotherapy, because patients always know
they are receiving that. Patients in the therapy conditions may
therefore have expectations of positive effects and hope that the
therapy will work. Patients in the medication condition on the
other hand do not have these hopes and expectations to the same
extent because they are uncertain whether they received medica-
tion or placebo. In a meta-analysis we therefore examined studies
comparing psychotherapy with pharmacotherapy in which a pla-
cebo was used separately from those in which no placebo was
used. The ones in which no placebo was used (and patients in both
conditions) is probably the best comparison. It was found that
pharmacotherapy was a little more effective than psychotherapy
(g  0.13) and this was significant.
On the other hand, however, many medication trials are spon-
sored by the industry and this may affect outcomes. That may also
be true for trials comparing psychotherapy and pharmacotherapy.
In a meta-analysis in which we explored the influence of sponsor-
ship on the outcomes of these trials, we found that in the industry-
funded trials pharmacotherapy was significantly more effective
than psychotherapy (g  0.11; Cristea, Gentili, Pietrini, &
Cuijpers, 2016). In the trials that were not funded (and are there-
fore probably more independent) there was no significant differ-
ence between the two treatments (g  0.10 in favour of psycho-
therapy).
So, overall it seems pretty robust that psychotherapy and phar-
macotherapy are about equally effective, although some factors
like blinding and sponsorship may result in small, clinically irrel-
evant differences in outcomes.
There is some evidence that the effects of psychotherapies last
longer than those of pharmacotherapy. There is a small group of
studies comparing patients receiving either CBT or pharmacother-
apy in the acute phase of treatment, which then examine what
happens in the follow-up period. Almost all studies had a
follow-up between 12 and 24 months after the end of the acute
phase treatment. In this follow-up period, the patients who had
received CBT in the acute phase received no treatment, except for
a few booster sessions in some studies. In five of the included
studies the patients in the pharmacotherapy condition continued to
take medication. The odds of responding to treatment were higher
in the CBT condition than in the continued pharmacotherapy
condition, but not significantly so (OR  1.62; 95% CI [0.97,
2.72]; NNT  10; Cuijpers, Hollon et al., 2013). In eight studies
in this meta-analysis, the patients in the pharmacotherapy condi-
tion discontinued treatment during follow-up (while patients in the
CBT condition did not receive any treatment). In these studies the
odds of responding were significantly better in the CBT conditions
at follow-up than in the pharmacotherapy conditions (OR  2.61;
95% CI [1.58, 4.31]; Cuijpers, Hollon et al., 2013).
Although psychotherapy and pharmacotherapy are probably
about equally effective in the short-term, it is clear that the com-
bination of the two is more effective than either of them alone (see
Table 1). In meta-analyses of trials examining these comparisons
we found that combined treatment is significantly more effective
than pharmacotherapy alone with an effect size of g  0.41
(NNT  4; Cuijpers et al., 2014), and than psychotherapy alone
with g  0.35 (NNT  5; Cuijpers, van Straten, Warmerdam, &
Andersson, 2009).
There is also a group of studies comparing combined treatment
with the combination of psychotherapy and placebo (Cuijpers, van
Straten, Hollon, & Andersson, 2010). These studies indicate the
exact contribution of the medication to the effects of combined
treatments. As can be seen in Table 1, medication contributes to
the effects of combined treatments by an effect size of g  0.25
(NNT  7).
Characteristics of Patients
We have conducted several meta-analyses in specific groups of
patients, such as older adults (Cuijpers, Karyotaki, Pot, Park, &
Reynolds, 2014; Cuijpers, van Straten, & Smit, 2006), college
students (Cuijpers, Cristea et al., 2016), and patients with general
medical disorders, such as diabetes, heart diseases, or cancer (van
Straten, Geraedts, Verdonck-de Leeuw, Andersson, & Cuijpers,
2010; see Table 3). In general, these studies show that the effects
of psychotherapies in specific subgroups are comparable with
those in adult populations in general.
In two meta-analyses we have compared the effects of psycho-
therapies in such specific groups (older adults, Cuijpers, van
Straten, Smit, & Andersson, 2009; and college students, Cuijpers,
Cristea et al., 2016) to studies of adults in general. We conducted
metaregression analyses, in which we compared these two groups
of studies, while controlling for other characteristics of the trials.
In both metaregression analyses we found no indication that the
effects differed between the specific populations and adults in
general.
We also conducted some meta-analyses in specific settings. In
one meta-analysis we examined the effects of psychotherapies in
inpatient settings and found an effect size of g  0.29 (95% CI
[0.13, 0.44]; Cuijpers, Clignet et al., 2011). This is somewhat
smaller than the effects found for therapies in other settings. The
reason is probably that in these trials a structured psychotherapy is
compared with usual care that typically involves quite intensive
care in inpatient settings, including psychological support and
therapy.
In another meta-analysis we examined the effects of psycho-
therapy in primary care patients (Cuijpers, van Straten, Van
Schaik, & Andersson, 2009). In this meta-analysis we found that
the effects were also somewhat smaller than in other settings (g 
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0.31; 95% CI [0.17, 0.45]; NNT  6). In a series of subgroup
analyses we found that in studies in which patients were referred
by their general practitioner the effects were comparable to those
in other settings. When patients were identified through systematic
screening of primary care patients, however, the effects were
considerably smaller and nonsignificant. The difference between
these two groups of studies was significant.
In our database we have included trials in which patients are
included if they meet diagnostic criteria for major depression or
another mood disorder. However, we have also included trials in
which a cut-off on a self-report measure is used as inclusion
criterion. In our meta-analyses we typically find no difference
between the effect sizes in these two groups of studies (Cuijpers,
Berking et al., 2013; Cuijpers, van Straten, Warmerdam, & Smits,
2008).
There is a considerable number of trials examining the effects of
psychotherapy in specific types of depression (see Table 3). In one
meta-analysis we examined studies in people with subthreshold
depression (depressive symptoms but no major depressive disor-
der). We found that the effects of psychotherapy in this group were
moderate but significant (g  0.35; 95% CI [0.23, 0.47]; NNT 
5). However, these effects were significantly smaller than in pa-
tients with a major depressive disorder. This is not surprising
because the level of depressive symptoms was low from the start
and there was less room for improvement. We also found that these
treatments significantly reduced the incidence of major depressive
episodes at 6 months follow-up (relative risk [RR]  0.61) and
possibly at 12 months (RR  0.74).
In another meta-analysis we focused on trials in patients with
chronic depression (Cuijpers, van Straten, Schuurmans et al.,
2010). We found that psychotherapy had a small but significant
effect (g  0.23; 95% CI [0.06, 0.41]) on depression when com-
pared with control groups. Psychotherapy was significantly less
effective than pharmacotherapy in direct comparisons
(g  0.31), especially SSRIs. This finding, however, was fully
attributable to dysthymic patients (the studies examining dysthy-
mia patients were the same studies that examined SSRIs). Com-
bined treatment was more effective than pharmacotherapy alone
but even more so with respect to psychotherapy alone, although
again this difference may have reflected the greater proportion of
dysthymic samples in the latter.
In one meta-analysis we examined trials combining CBT and
motivational interviewing to treat comorbid depression and alco-
hol use disorder. We found that the effects of this intervention on
depression were small but significant (g  0.27; 95% CI: 0.13 
0.41; NNT  7), as were the effects on alcohol (g  0.17; 95% CI:
0.07  0.28; Riper et al., 2014). And finally, in another meta-
analysis we found that the effects of psychological treatments of
women with postpartum depression were large and comparable
with those in other populations (g  0.61; 95% CI [0.37, 0.85];
NNT  3).
We have examined several other characteristics of patients in
our meta-analyses. For example we examined whether the propor-
tion of people from ethnic minorities in the trials was associated
with the effect size (Unlu Ince, Riper, van ‘t Hof, & Cuijpers,
2014). We used subgroup and metaregression analyses. We did not
find a significant association between the proportion of people
from ethnic minorities and the effect size. In another metaregres-
sion analyses we examined whether the mean severity of the
population in the trials at baseline predicted outcome (Driessen,
Table 3
Characteristics of Participants and of the Psychotherapies
N g 95% CI I2 95% CI NNT Reference
Psychotherapy for specific target groups versus control groups
• Older adults 40 .64 [.47, .80] 80 [73, 85] 3 (Cuijpers, Karyotaki et al., 2014)
• Student populations 22 .89 [.66, 1.11] 57 [23, 72] 2 (Cuijpers, Cristea et al., 2016)
• Patients with general medical disorders 18 1.00 [.57, 1.44] 93 [90, 94] 2 (van Straten et al., 2010)
Settings
• Patients in primary care 20 .31 [.17, .45] 46 [0, 67] 6 (Cuijpers, van Straten, van Schaik et al., 2009)
• Inpatients 15 .29 [.13, .44] 0 [0, 46] 6 (Cuijpers, Clignet et al., 2011)
Subtypes of depression
• Patients with subthreshold depression 14 .35 [.23, .47] 13 [0, 51] 5 (Cuijpers, Koole et al., 2014)
• Patients with chronic depression 8 .23 [.06, .41] 0 [0, 56] 8 (Cuijpers, van Straten, Schuurmans et al., 2010)
• Women with postpartum depression 19 .61 [.37, .85] 65 [37, 77] 3 (Cuijpers, Brannmark, & van Straten, 2008)
Characteristics of therapies
• Individual versus group psychotherapies 19 .20 [.05, .35] 0 [0, 43] 9 (Cuijpers, van Straten, & Warmerdam, 2008)
• Guided self-help versus face-to-face therapies 9 .15 [.41, .11] 2 [0, 55] 12 (Cuijpers, Sijbrandij et al., 2014)
• Number of sessionsa
• 4–6 23 .47 [.30, .65] 45 [9, 66] 4 (Cuijpers, Huibers et al., 2013)
• 7–10 27 .58 [.42, .74] 69 [55, 79] 3 (Cuijpers, Huibers et al., 2013)
• 12–16 22 .68 [.50, .85] 57 [30, 73] 3 (Cuijpers, Huibers et al., 2013)
• 18–24 20 .61 [.41, .81] 42 [1, 66] 3 (Cuijpers, Huibers et al., 2013)
• Sessions per week (p  .001)
• 1 10 .44 [.19, .69] 64 [29, 82] 4 (Cuijpers, Huibers et al., 2013)
• 1 46 .58 [.46, .70] 53 [35, 67] 3 (Cuijpers, Huibers et al., 2013)
• 1 22 .71 [.52, .91] 53 [24, 71] 3 (Cuijpers, Huibers et al., 2013)
Note. CI  confidence interval; N  number of comparisons; NNT  numbers-needed-to-treat.
a This meta-analysis was conducted only in individual therapies.
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Cuijpers, Hollon, & Dekker, 2010). We found no indication that
baseline severity was associated with outcome. This suggests that
psychotherapy is also effective in patients with severe depression.
The problem with such metaregression analyses is that they can
only be conducted with the aggregated data from each study, and
not with the data of individual patients. So, the mean depression
score at baseline from one study says very little about the range
of severities of depression in that trial. In one of the subprojects of
our meta-analysis project, we started to collect the primary data of
trials in order to conduct so-called “individual patient data” (IPD)
meta-analyses (Riley, Lambert, & Abo-Zaid, 2010). With the
individual data from trials it is possible to examine characteristics
of individual participants (such as baseline severity) and examine
them across trials. One advantage is also that individual trials
typically do not have enough statistical power to examine moder-
ators of outcome. However, by combining the data of individual
trials the statistical power increases considerably, making such
analyses of moderators possible.
We are currently in the process of collecting the data of trials for
several comparisons. However, we have already successfully col-
lected the data of 16 randomized trials comparing CBT with
pharmacotherapy for depression with more than 1,700 patients.
The first articles about these data have now been published. We
have shown that, contrary to what is thought by many clinicians,
baseline severity is not a significant predictor of outcome and CBT
is as effective in severe depression as pharmacotherapy (Weitz et
al., 2015). In another article based on these data we showed that
deterioration of patients and extreme nonresponse in trials com-
paring CBT and pharmacotherapy is rare, and not significantly
different in the two treatment modalities. (Vittengl et al., 2016)
Finally, we showed that gender is not a predictor or moderator of
outcome in CBT and pharmacotherapy (Cuijpers, Weitz et al.,
2014). We also found that there is no difference in effects between
CBT and pharmacotherapy in patients with melancholic depres-
sion or with atypical depression (Cuijpers et al., in press).
Characteristics of Therapies
In several meta-analyses we examined whether characteristics
of therapies are associated with the effect sizes. Previously we
already saw that type of therapy does not seem to be very strongly
related to outcome of therapies. In an early meta-analysis we found
that professionally trained therapists did not appear to realise
higher effect sizes than trained students who delivered the thera-
pies (Cuijpers, van Straten, Warmerdam et al., 2008). However,
this meta-analysis is already somewhat older and was based on
only a limited number of studies, so this finding has to be verified
in future research.
We have also examined in several meta-analyses whether treat-
ment format is related to outcome. In one meta-analysis we in-
cluded trials in which individual and group therapies were directly
compared with each other (Cuijpers, van Straten, van Oppen et al.,
2008). Individual therapy seemed to be somewhat more effective
than group therapy (g  0.20; 95% CI [0.05, 0.35]; NNT  9).
Furthermore drop-out from treatment seemed to be somewhat
smaller in individual therapy. However, the quality of these studies
was low. Therefore, the results have to be considered with caution
and may very well reflect a chance finding. This is especially true
because this finding was not confirmed in moderator analyses of
controlled trials in which typically no indication is found that
individual or group treatment differ significantly from each other
(Cuijpers, Berking et al., 2013; Cuijpers, van Straten, Warmerdam
et al., 2008).
In general it seems that the treatment format is not or not
strongly related to outcome, whether that format is individual,
group, or guided self-help (through a book or through computer-
ized therapy). In one meta-analysis we found that Internet-based
guided self-help interventions are effective compared with control
conditions with an effect size that is comparable with those of
face-to-face therapies (g  0.61; 95% CI [0.45, 0.77]; Andersson
& Cuijpers, 2009). In another meta-analysis we selected trials in
which face-to-face therapies were directly compared with guided
self-help therapies. In guided self-help interventions patients apply a
written psychological treatment to themselves. The therapist only
helps the patient to work through the materials. The meta-analysis
comparing face-to-face therapies with guided self-help found no sig-
nificant difference between the two treatment formats (g  0.15;
95% CI [0.41, 0.11]).
In general we can say that treatment format is not or only to a
limited extent associated with the effects of treatment. However,
this is only true for the individual, group, and guided self-help
formats. Because the Internet is becoming increasingly integrated
in societies, several unguided interventions for depression have
become available. A growing number of trials have examined the
effects of these treatments. In a meta-analysis of such trials we
found that unguided treatment of depression has significant effects
on depression (g  0.28; 95% CI [0.14, 0.42]), but these effects are
considerably smaller than those of individual, group, and guided
self-help interventions (Cuijpers, Donker et al., 2011).
In another meta-analysis we examined whether the amount,
frequency, and intensity of therapy was related to the effect sizes
(in this meta-analysis we only included studies on individual
therapies; Cuijpers, Huibers, Ebert, Koole, & Andersson, 2013).
There was only a small association between number of therapy
sessions and effect size. Furthermore, this association was no
longer significant when the analysis adjusted for other character-
istics of the studies. In metaregression analyses we also found no
significant association with the total contact time or duration of the
therapy. However, there was a strong association between number
of sessions per week and effect size. An increase from one to two
sessions per week boosted the effect size by g  0.45, while
keeping the total number of treatment sessions constant. We are
currently verifying in a randomized trial whether this association is
indeed robust (Bruijniks et al., 2015).
Causes of Overestimation of the Effects
In most meta-analyses described to date psychotherapy has been
found to have moderate to large effects on depression. However,
we also found indications that these effects are considerably over-
estimated (Cuijpers, Andersson et al., 2011).
In one meta-analysis we examined the association between
quality of trials and the effect size (Cuijpers, Andersson et al.,
2011; Cuijpers, van Straten, Bohlmeijer, Hollon, & Andersson,
2010). We assessed eight quality criteria: participants met diag-
nostic criteria for a depressive disorder, a treatment manual was
used, the therapists were trained, treatment integrity was checked,
intention-to-treat analyses were used, N  50, randomization was
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conducted by an independent party, and assessors of outcome were
blinded. Out of the 115 trials, only 11 (with 16 comparisons
between therapy and control) met all eight quality criteria. The
effect size found for the high-quality studies (g  0.22; 95% CI
[0.14, 0.31]; NNT  8) was significantly smaller than in the other
studies (g  0.75; 95% CI [0.66, 0.84]; NNT  2). That was even
true after restricting the sample to the subset of other studies that
used the kind of care-as-usual or nonspecific controls that tended
to be used in the high-quality studies.
Another reason why the effects of psychotherapies have been
overestimated is publication bias. Publication bias is the tendency
for authors to submit, or journals to accept, manuscripts for pub-
lication based on the direction or strength of the study’s findings
(Dickersin, 1990). We identified U.S. National Institutes of Health
grants funding randomized clinical trials on psychological treat-
ments and we determined whether those grants led to publications
(Driessen, Hollon, Bockting, Cuijpers, & Turner, 2015). A total of
13 (24%) of the 55 funded grants did not result in publications. We
also requested the data of the unpublished studies from the re-
searchers. We found that among the comparisons of therapy to
control conditions, adding unpublished studies to published studies
reduced the psychotherapy effect size by 25%, from g  0.52
(95% CI [0.37, 0.68]) to g  0.39 (95% CI [0.08, 0.70]).
This direct evidence of publication bias is in line with more
indirect evidence we have found in our meta-analyses (Cuijpers,
Smit, Bohlmeijer, Hollon, & Andersson, 2010). The indirect evi-
dence for publication bias can be based on the symmetry of the
funnel plot. A funnel plot gives a measure of study size (the
standard error) on the vertical axis as a function of effect size on
the horizontal axis. Large studies appear at the top of the graph and
tend to cluster near the mean effect size. Smaller studies appear
toward the bottom of the graph. As there is more sampling vari-
ation in effect size estimates in the smaller studies, they will be
dispersed across a larger range of values than large studies. Studies
can be expected to be distributed symmetrically about the pooled
effect size when publication bias is absent. In the presence of bias,
it can be expected that the lower part of the plot will show a higher
concentration of studies on one side of the mean than on the other.
It is possible to calculate the effect size after adjustment for this
asymmetry of the funnel plot (Duval & Tweedie, 2000). We found
in a meta-analysis of 175 comparisons between a therapy and
control group that the overall effect size was g  0.67 (95% CI
[0.60, 0.75]), but after adjustment for publication bias this was
reduced to g  0.42 (95% CI [0.33, 0.51]; number of missing
studies was 51).
This analysis shows that the effects of psychotherapy for de-
pression have probably been considerably overestimated. The true
effects are smaller than has been assumed on the basis of earlier
meta-analyses.
Directions for Future Research
In the series of meta-analyses described in this article, it became
clear that psychological interventions are effective in the treatment
of depression. Based on four decades of research on these inter-
ventions we also learned much about the characteristics of the
participants of these interventions, as well as about the types,
formats, and contents of these interventions. However, we also saw
that the effects of psychotherapies have been overestimated be-
cause of the low quality of many trials and because of publication
bias. So, how should the field move forward in the next decades?
It is clear that there is a strong need for further reduction of the
disease burden of depression. As we saw in the introduction of this
article, the disease burden of depression is very high. It is high in
terms of personal suffering among patients and their families, as
well as from a societal and economic perspective. And although
current treatments are considered to be effective, there is also
much room for improvement (Cuijpers, 2015). Modelling studies
have shown that all available evidence-based treatments together
can reduce the disease burden of depression by only about 33%
(Andrews, Issakidis, Sanderson, Corry, & Lapsley, 2004). More
than 40% of the patients only partially respond to treatment if at
all, and less than one third of the patients are completely recovered
after treatment (Hollon et al., 2002). Furthermore, relapse rates are
estimated to be 50% after 2 years and up to 85% within 15 years
after recovery from an initial episode (Mueller et al., 1999).
So, from a public health perspective it is very important to
improve treatment outcomes for depression and to further reduce
the disease burden. How can that be realised? One important
direction for the future is not to waste funding and resources on
research that is not needed and will not contribute to a further
reduction of the disease burden of depression. The 500 trials on
psychotherapy for depression that have been conducted in the past
decades have made it clear that although many new therapies have
been developed for depression, none of them is more effective than
the others. Despite claims of being superior to existing therapies,
no new therapy for depression has been found to be better than the
existing ones. This finding of no superiority of one therapy over
others cannot be considered as evidence that there are indeed no
differences. However, it is very unlikely that a new therapy would
suddenly appear and turn out to be more effective than existing
ones. If a reduction of the disease burden is the goal of future
research it would be unwise to spend available resources on that.
We have seen this too often in the past and end up with just another
therapy that is equally effective but does not add anything to a
further reduction of the disease burden.
The same is true for research on different treatment formats.
Individual, group, and guided self-help (including Internet-based)
formats are probably (about) equally effective. However, this
research cannot be completely certain about whether there are no
differences; if there are any they are probably small and not
clinically relevant. But again, if a reduction of the disease is our
primary aim, this is not what we should focus on. The same is true
for trials in specific populations. The research from the past
decades suggests that psychotherapies are effective in all adults.
There is no reason that it is not effective in specific subgroups such
as older adults, patients with general medical disorders, and col-
lege students.
But if we should not focus our research on new therapies,
treatment formats, or specific populations, what should the targets
of future research be? Of course there is a lot we need to know
about depression outside the therapy field. For example, we need
more understanding of what depression is, the biological and
psychological mechanisms and etiology involved, the heterogene-
ity of depression, and possible subcategories. We also need better
and more accurate diagnostic tools.
But in the field of psychological interventions there are several
goals for future research that are important from a public health
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perspective. First, preventive interventions are an important topic.
Because current treatments can take away only one third of the
disease burden of depression, maybe prevention can remove a part
of the other two thirds? There is a considerable number of trials
showing that selective and indicated interventions can prevent the
onset of new cases of major depression at one to 2-year follow-up
(Cuijpers, van Straten, Warmerdam, & Andersson, 2008; van
Zoonen et al., 2014).
Another important way to improve outcomes and reduce the
disease burden is by focusing on treatments of chronic and
treatment-resistant depression, and on preventing relapse
(Cuijpers, 2015). Many patients suffer from depressive disorder
for a considerable time period and do not respond to treatments, or
they relapse after successful recovery. If we want to reduce the
disease burden of depression further, this is one of the main
subjects we should focus on. Fortunately, the number of trials in
chronic depression and relapse prevention is growing. Several
psychological therapies specifically aimed at chronic depres-
sion have been developed and tested (Carter et al., 2013;
Rohricht, Papadopoulos, & Priebe, 2013; Schramm et al., 2011;
Strauss, Hayward, & Chadwick, 2012; Wiles et al., 2013).
Other trials have provided further evidence that relapse can be
effectively prevented with cognitive behaviour therapy (Jarrett,
Minhajuddin, Gershenfeld, Friedman, & Thase, 2013), espe-
cially in patients with a higher number of previous episodes
(Stangier et al., 2013).
Another important way to further reduce the disease burden of
depression is to develop methods for applying psychological treat-
ments in a simpler and more efficient way (Cuijpers, 2015).
Psychotherapies have not been scaled up to the extent that they
may help reduce the disease burden of mental disorders (Kazdin &
Blase, 2011). Even in high-income countries less than half the
people with depressive disorders receive treatment. This is much
lower in low and middle income countries, but also in older adults,
people with lower socioeconomic status, and people from ethnic
minorities. Scaling up treatments can be realized, for example, by
training lay health counselors to deliver psychological therapies
(Patel et al., 2010). This is especially interesting in low- and
middle-income countries that want to build an infrastructure for
mental health care, while fully trained therapists are not available.
In addition, guided self-help interventions (including Internet-
based interventions) can be useful for scaling up treatments, as has
been done in the United Kingdom in the Increasing Access to
Psychological Therapies program (Gyani, Shafran, Layard, &
Clark, 2013). Such treatments save therapists’ time and are prob-
ably as effective as face-to-face therapies, while requiring fewer
resources.
Discussion
In this article we presented an overview of a series of meta-
analyses we conducted on the 500 randomized trials that have
examined the effects of psychological treatments of adult depres-
sion. We saw that several of these interventions have been tested
and that they are effective in the treatment of depression. Further-
more, we saw that there are no significant differences between
treatments and that they have effects that last for 6 to 12 months.
We also saw that these therapies are about equally effective as
pharmacotherapy in the short-term, and that the combination of
psychotherapy and antidepressants is significantly more effective
than either of these alone. Therapies are also effective in specific
target groups, such as older adults, college students, women with
postpartum depression, and patients with general medical disor-
ders. These therapies may be somewhat less effective in chronic
depression, and in patients with comorbid substance use disorders.
Treatments are effective when delivered in individual, group, and
guided self-help format. They are less effective when delivered
without any kind of human support. We also saw that the effects
of psychotherapies have been overestimated because of the low
quality of many trials as well as publication bias.
As directions for future research we suggested not to develop
new psychotherapies for depression because up to now all new
therapies appeared to be indeed effective in the treatment of
depression, but not more so than existing therapies. We also
suggested not to test treatment formats and therapies in specific
populations, because the evidence indicates that all formats with
human involvement are effective in all specific target groups.
Additionally, we recommended that a focus on a reduction of the
disease burden of depression should be the starting point for new
research. Promising areas include research on preventing the onset
of depressive disorders, treatments of chronic and treatment-
resistant depression, relapse prevention, and scaling up treatments
for example by using more guided self-help interventions and
training lay counselors in delivering interventions in low-resource
settings.
Although this is a comprehensive overview of all the meta-
analyses we have conducted in the past years, it contains some
limitations. First, we only presented the meta-analyses that were
conducted by us based on our database. There are, however, many
other meta-analyses and these do not necessarily reach the same
conclusions. Second, we merely summarised the results of these
meta-analyses, but did not discuss all the results in terms of
heterogeneity, moderator analyses, and analyses of publication
bias from each of these meta-analyses.
Despite these limitations, we can conclude that psychotherapies
are essential tools in the treatment of adult depression. Random-
ized trials have shown that these treatments are effective, and by
focusing on key issues, such as chronic and treatment-resistant
depression, on relapse, and on scaling up, psychotherapies con-
tribute more and more to the reduction of the disease burden of
depression.
Résumé
Au cours des 4 dernières décennies, environ 500 essais randomisés
ont examiné les effets des traitements psychologiques de la dé-
pression chez l’adulte. Cet article fait le sommaire des résultats
d’une série de méta-analyses de ces essais. Plusieurs types de
psychothérapie ont été examinés, y compris la thérapie cognitivo-
comportementale, la thérapie d’activation comportementale, la
psychothérapie interpersonnelle, la thérapie de résolution de
problèmes, la thérapie de soutien non directive et la psychothérapie
psychodynamique à court terme. Toutes les thérapies sont effi-
caces et il n’y a pas de différences significatives entre les traite-
ments. Les psychothérapies sont à peu près aussi efficaces que la
pharmacothérapie, et les traitements combinés sont plus efficaces
que toute méthode utilisée seule. De plus, les thérapies sont effi-
caces parmi des groupes cibles précis, tels les aînés, les étudiants
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à l’université ou les patients ayant des troubles de santé, mais
quelque peu moins efficaces pour traiter la dépression chronique
ou des troubles concomitants de toxicomanie. Les traitements
sont efficaces lorsqu’ils sont offerts sur une base individuelle,
en groupe ou selon un format d’aide personnelle autoguidée.
L’efficacité des psychothérapies a été surestimée en raison de la
faible qualité de nombreux essais et d’un biais de publication.
Les recherches futures ne devraient pas viser à élaborer de
nouvelles psychothérapies pour traiter la dépression ou encore
de nouvelles formules de traitement ou de thérapies destinées à
des populations précises, car les preuves révèlent que tous les
types et formats impliquant une participation humaine sont
efficaces parmi tous les groupes ciblés. Les recherches futures
devraient plutôt se consacrer à diminuer davantage le fardeau
de la maladie qu’est la dépression. Plus précisément, elles
devraient se pencher sur les possibilités de prévenir les troubles
dépressifs, sur les traitements de la dépression chronique et de
la dépression réfractaire au traitement, la prévention des re-
chutes, l’intensification des traitements au moyen, par exemple,
des interventions d’aide personnelle autoguidée.
Mots-clés : dépression, méta-analyse, psychothérapie, traitement
psychologique, thérapie cognitivo-comportementale.
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